Patents by Inventor Heather Kay
Heather Kay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240150314Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).Type: ApplicationFiled: October 2, 2023Publication date: May 9, 2024Inventors: Sampath Kumar ANANDAN, Joshua ODINGO, Heather Kay Webb HSU, Vincent FLORIO, Subramanyam Janardhan TANTRY, Athisayamani Jeyaraj DURAISWAMY
-
Publication number: 20230416802Abstract: Provided are HSD17B13 substrates, reaction products, kits, and methods that include the HSD17B13 substrates or reaction products of the HSD17B13 substrates. Some embodiments include methods of treatment. Some such embodiments include determining an amount of an HSD17B13 substrate or of a reaction product of the HSD17B13 substrate in a sample from the subject to whom the HSD17B13 substrate has been administered.Type: ApplicationFiled: November 3, 2021Publication date: December 28, 2023Inventors: Heather Kay Webb HSU, Vincent FLORIO, Michael CARLETON, Joshua ODINGO
-
Patent number: 11827619Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).Type: GrantFiled: May 10, 2023Date of Patent: November 28, 2023Assignee: INIPHARM, INC.Inventors: Sampath Kumar Anandan, Joshua Odingo, Heather Kay Webb Hsu, Vincent Florio, Subramanyam Janardhan Tantry, Athisayamani Jeyaraj Duraiswamy
-
Publication number: 20230286923Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).Type: ApplicationFiled: July 23, 2021Publication date: September 14, 2023Inventors: Joshua ODINGO, Sampath Kumar ANANDAN, Heather Kay Webb HSU, Vincent FLORIO, Subramanyam Janardhan TANTRY, Athisayamani Jeyaraj DURAISWAMY, Bharathi Mohan KUPPUSAMY
-
Publication number: 20230278978Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).Type: ApplicationFiled: July 23, 2021Publication date: September 7, 2023Inventors: Joshua ODINGO, Sampath Kumar ANANDAN, Heather Kay Webb HSU, Vincent FLORIO, Subramanyam Janardhan TANTRY, Athisayamani Jeyaraj DURAISWAMY
-
Publication number: 20230278981Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).Type: ApplicationFiled: May 10, 2023Publication date: September 7, 2023Inventors: Sampath Kumar ANANDAN, Joshua ODINGO, Heather Kay Webb HSU, Vincent FLORIO, Subramanyam Janardhan TANTRY, Athisayamani Jeyaraj DURAISWAMY
-
Publication number: 20230150940Abstract: Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).Type: ApplicationFiled: April 16, 2021Publication date: May 18, 2023Inventors: Joshua ODINGO, Heather Kay Webb HSU, Vincent FLORIO, Subramanyam Janardhan TANTRY, Rajendra KRISTAM, Athisayamani Jeyara DURAISWAMY
-
Publication number: 20110078571Abstract: Methods, computer readable media, and apparatuses for providing visual responses to musically synchronized touch input are presented. A moving object may be displayed on a touch-sensitive display. Subsequently, a first display characteristic of the moving object may be changed synchronously with a beat of an audio track being played. Thereafter, in response to receiving user input corresponding to a tap on the moving object that is synchronized with the beat, the moving object may be altered in a first manner. In response to receiving user input corresponding to a tap on the moving object that is not synchronized with the beat, the moving object may be altered in a second manner different from the first manner. Optionally, a second display characteristic of the moving object may be changed to signal a user of the approaching beat prior to changing the first display characteristic of the moving object.Type: ApplicationFiled: September 29, 2010Publication date: March 31, 2011Applicant: Monstrous CompanyInventors: Jason Lee Asbahr, Heather Kay Dority, Edward McNeely Robinson
-
Publication number: 20090197916Abstract: Compounds, compositions, and methods for inhibiting the onset of metabolic syndrome and treating related disorders in a subject in need of such therapy are disclosed.Type: ApplicationFiled: November 4, 2008Publication date: August 6, 2009Inventors: Yi-Xin (Jim) Wang, Le-Ning Zhang, Heather Kay Webb Hsu
-
Publication number: 20080221105Abstract: Compounds, compositions, and methods for inhibiting the onset of metabolic syndrome and treating related disorders in a subject in need of such therapy are disclosed.Type: ApplicationFiled: January 28, 2008Publication date: September 11, 2008Inventor: Heather Kay Webb Hsu
-
Publication number: 20080221104Abstract: Methods for reducing autoimmune induced inflammation, including rheumatoid arthritis in a subject in need of such therapy are disclosed.Type: ApplicationFiled: November 2, 2007Publication date: September 11, 2008Inventor: Heather Kay Webb Hsu
-
Publication number: 20060144244Abstract: A concentrate/extract cartridge for a beverage dispenser for dispensing a liquid concentrate/extract and a diluent is provided. The cartridge includes a hollow body and a dispensing tube connected to the hollow body. A piston is slideably contained by the dispensing tube. The cartridge includes a valve having a valve stem that passes through a port of a valve seat connected to the dispensing tube. The port defines a flow passage through the dispensing tube. The valve stem is connected to the piston at a first end of the valve stem, and a valve body is located at a second end of the valve stem in removable contact with the valve seat for alternately opening and closing the port. A beverage dispenser having a removably insertable concentrate/extract cartridge and a method of dispensing a beverage made from concentrate/extract and a diluent are also provided.Type: ApplicationFiled: November 3, 2005Publication date: July 6, 2006Applicant: Intelligent Coffee Company, LLCInventors: Jeffrey Girard, Nasser Pirshafiey, Mario Vassaux, Heather Kay, Shlomo Greenwald, Zipora Greenwald
-
Patent number: 6867014Abstract: The present invention provides an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution such as blood, blood derivatives, or urine. The assay comprises the steps of contacting the solution containing homocysteine and/or cystathionine to form a reaction mixture, with CBS, or a derivative thereof, L-serine, and CBL, or a derivative thereof, for a time period sufficient to catalyze the cyclical conversion of homocysteine form to cystathionine and the reconversion of cystathionine to homocysteine with the production of pyruvate and ammonia; determining the amount of homocysteine and/or ammonia present in the reaction mixture; and determining the amount of homocysteine and/or cystathionine present in the solution based on the amount of pyruvate and/or ammonia formed. Expression vectors and isolation procedures for CBS, or derivatives thereof, and CBL, or derivatives thereof, are also provided as well as test kits for carrying out the assay.Type: GrantFiled: August 28, 2003Date of Patent: March 15, 2005Inventors: Glenn Kawasaki, Heather Kay Webb, Jeffrey Owens, Raymond Liedtke, Doreen Forest, Mark Legaz, Sobomabo Lawson
-
Publication number: 20040096929Abstract: The present invention provides an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution such as blood, blood derivatives, or urine. The assay comprises the steps of contacting the solution containing homocysteine and/or cystathionine to form a reaction mixture, with CBS, or a derivative thereof, L-serine, and CBL, or a derivative thereof, for a time period sufficient to catalyze the cyclical conversion of homocysteine form to cystathionine and the reconversion of cystathionine to homocysteine with the production of pyruvate and ammonia; determining the amount of homocysteine and/or ammonia present in the reaction mixture; and determining the amount of homocysteine and/or cystathionine present in the solution based on the amount of pyruvate and/or ammonia formed. Expression vectors and isolation procedures for CBS, or derivatives thereof, and CBL, or derivatives thereof, are also provided as well as test kits for carrying out the assay.Type: ApplicationFiled: August 28, 2003Publication date: May 20, 2004Inventors: Glenn Kawasaki, Heather Kay Webb, Jeffrey Owens, Raymond Liedtke, Doreen Forest, Mark Legaz, Sobomabo Lawson
-
Patent number: 6664073Abstract: The present invention provides an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution such as blood, blood, derivatives, or urine. The assay comprises the steps of contacting the solution containing homocysteine and/or cystathionine to form a reaction mixture, with CBS, or a derivative thereof, L-serine, and CBL, or a derivative thereof, for a time period sufficient to catalyze the cyclical conversion of homocysteine form to cystathionine and the reconversion of cystathionine to homocysteine with the production of pyruvate and ammonia; determining the amount of homocysteine and/or ammonia present in the reaction mixture; and determining the amount of homocysteine and/or cystathionine present in the solution based on the amount of pyruvate and/or ammonia formed. Expression vectors and isolation procedures for CBS, or derivatives thereof, and CBL, or derivatives thereof, are also provided as well as test kits for carrying out the assay.Type: GrantFiled: November 1, 2000Date of Patent: December 16, 2003Assignee: Catch Inc.Inventors: Glenn Kawasaki, Heather Kay Webb, Jeffrey Owens, Raymond Liedtke, Doreen Forest, Mark Legaz, Sobomabo Lawson
-
Patent number: 6635438Abstract: The present invention provides an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution such as blood, blood derivatives, or urine. The assay comprises the steps of contacting the solution containing homocysteine and/or cystathionine to form a reaction mixture, with CBS, or a derivative thereof, L-serine, and CBL, or a derivative thereof, for a time period sufficient to catalyze the cyclical conversion of homocysteine form to cystathionine and the reconversion of cystathionine to homocysteine with the production of pyruvate and ammonia; determining the amount of homocysteine and/or ammonia present in the reaction mixture; and determining the amount of homocysteine and/or cystathionine present in the solution based on the amount of pyruvate and/or ammonia formed. Expression vectors and isolation procedures for CBS, or derivatives thereof, and CBL, or derivatives thereof, are also provided as well as test kits for carrying out the assay.Type: GrantFiled: November 6, 2001Date of Patent: October 21, 2003Assignee: Catch, Inc.Inventors: Glenn Kawasaki, Heather Kay Webb, Jeffrey Owens, Doreen Forest, Raymond Liedtke, Sobomabo Lawson, Mark Legaz
-
Publication number: 20030138872Abstract: The present invention provides an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution such as blood, blood derivatives, or urine. The assay comprises the steps of contacting the solution containing homocysteine and/or cystathionine to form a reaction mixture, with CBS, or a derivative thereof, L-serine, and CBL, or a derivative thereof, for a time period sufficient to catalyze the cyclical conversion of homocysteine form to cystathionine and the reconversion of cystathionine to homocysteine with the production of pyruvate and ammonia; determining the amount of homocysteine and/or ammonia present in the reaction mixture; and determining the amount of homocysteine and/or cystathionine present in the solution based on the amount of pyruvate and/or ammonia formed. Expression vectors and isolation procedures for CBS, or derivatives thereof, and CBL, or derivatives thereof, are also provided as well as test kits for carrying out the assay.Type: ApplicationFiled: November 6, 2001Publication date: July 24, 2003Inventors: Glenn Kawasaki, Heather Kay Webb, Jeffrey Owens, Doreen Forest, Raymond Liedtke, Sobomabo Lawson, Mark Legaz
-
Publication number: 20020156023Abstract: The present invention provides compositions and methods for treating proliferative disorders using combination therapies of lometrexol and other therapeutically active agents. The methods include administration of lometrexol with one or more therapeutically active agents where lometrexol and the therapeutically active agent(s) are delivered in a single composition, where they are administered in separate compositions in a simultaneous manner, where lometrexol is administered first, followed by the therapeutically active agent(s), as well as where the therapeutically active agent(s) is delivered first, followed by lometrexol. In preferred embodiments, the therapeutically active agent(s) has antiproliferative properties.Type: ApplicationFiled: December 5, 2001Publication date: October 24, 2002Applicant: Tularik Inc.Inventors: Jacqueline Mary Walling, Heather Kay Webb, Alan Hilary Calvert, David R. Newell